Investing in mature HealthTech companies. Accelmed is a global group of funds investing in HealthTech companies (medical device, diagnostics and digital health) across all stages. We currently invest through two separate arms: Accelmed Partners a US based lower market private equity HealthTech fund, focused on Buyout and Growth Investments in commercial HealthTech (>$10M LTM) companies. Accelmed Ventures an Israel based venture fund, focused on pre-commercialization and early revenue HealthTech Opportunities. Acquiring commercial HealthTech companies and fostering significant value creation by supporting management teams, driving innovation, providing growth capital and potentially integrating innovative add-on technologies, largely from Israel. Accelmed Partners brings its expertise in HealthTech and its presence in the US and Israel to the Buyout model. With a broad geographic lens and deep experience in the field, Accelmed is uniquely positioned to find and drive value for portfolio companies. We are looking to partner with companies that have significant commercial infrastructure (>$20M LTM Revenue), an existing customer base and established sales channels, but that may lack new products and growth, and are interested in scaling and growing their businesses by gaining access to innovative products and growth capital. Accelmed Partners targets equity investments of $10-50M per transaction.

Venture Capital

Max Cheque


Min Cheque

Artificial Intelligence, Deep Learning, Machine Learning, Natural Language Processing
Hardware, Software


Uri Geiger
Managing Partner

Investment Portfolio

Investment Round History

June 6, 2021
Series B

Funds Raised

March 2021
$400000000 M
Fund II
October 2019
$400000000 M
December 2015
$100000000 M



Register Pro to view more


$25 per month

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database

Select a Table to Export